Login / Signup

The value of patient-reported outcomes in early-phase clinical trials.

Ameeta RetzerOlalekan Lee AiyegbusiAnna RowePhilip N NewsomeJessica Anne DouglasSheeba KhanSaloni MittalRoger WilsonDaniel O'ConnorLisa CampbellSandra A MitchellMelanie Jane Calvert
Published in: Nature medicine (2022)
Keyphrases
  • patient reported outcomes
  • clinical trial
  • phase ii
  • open label
  • double blind